Join the Pericarditis group to help and get support from people like you.
Pericarditis News
Related terms: Dressler's syndrome, Pericarditis, after heart attack, Post-cardiac injury syndrome, Post-MI pericarditis, Postcardiotomy pericarditis
COVID Vaccine Labels To Warn of Rare Heart Risk
FRIDAY, June 27, 2025 — The U.S. Food and Drug Administration (FDA) has added new warnings to the Pfizer and Moderna COVID-19 vaccines about a rare heart condition that mostly affects young men. The u...
Pericarditis Recurrence Occurs in About 20 Percent of Patients With Lupus
TUESDAY, March 4, 2025 – For patients with systemic lupus erythematosus (SLE) and pericarditis, recurrence of pericarditis occurs in more than 20 percent of patients and associated factors include...
Decision Pathway Developed for Diagnosing, Managing Myocarditis
TUESDAY, Dec. 17, 2024 – In a 2024 guidance document issued by the American College of Cardiology and published online Dec. 10 in the Journal of the American College of Cardiology, recommendations...
Mild Initial Clinical Course Seen for COVID-19 Vaccine-Linked Myocarditis
THURSDAY, Sept. 19, 2024 – COVID-19 vaccine-associated myocarditis (C-VAM) has a mild initial clinical course, but myocardial injury is common, according to a study published online in the October...
Fewer Complications at 18 Months Seen With Post-COVID-19 Vaccination Myocarditis
THURSDAY, Aug. 29, 2024 – Patients with post-COVID-19 mRNA vaccination myocarditis show a lower frequency of cardiovascular complications than those with conventional myocarditis or post-COVID-19...
Kiniksa Announces FDA Approval of Arcalyst (rilonacept) for Recurrent Pericarditis
HAMILTON, Bermuda, March 18, 2021 (GLOBE NEWSWIRE) – Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) (Kiniksa), a biopharmaceutical company with a portfolio of assets designed to modulate immunological...